Merck & Co., Inc., Rahway, NJ, USA.
Arcana Institute, a Certara Company, Krakow, Poland.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2319426. doi: 10.1080/21645515.2024.2319426. Epub 2024 Feb 27.
The uptake of human papillomavirus (HPV) vaccine remains suboptimal despite being a part of routine vaccination within national immunization program(s). This indicates probable challenges with the implementation of HPV immunization program(s) in various countries. The objective of this systematic literature review (SLR) was to identify implementation strategies for HPV vaccination within national and regional immunization programs worldwide with an aim to provide guidance for countries targeting to increase their HPV vaccine coverage rate (VCR). A comprehensive literature search was conducted across Medline and Embase and included articles published between January 2012 and January 2022. Of the 2,549 articles retrieved, 168 met inclusion criteria and were included in the review. Strategies shown to improve HPV vaccination uptake in the reviewed literature include campaigns to increase community awareness and knowledge of HPV, health care provider trainings, integrating HPV vaccination within school settings, coordinated efforts via multi-sectoral partnerships, and vaccination reminder and recall systems. Findings may help national authorities understand key considerations for HPV vaccination when designing and implementing programs aiming to increase HPV VCR in adolescents.
尽管人乳头瘤病毒 (HPV) 疫苗已纳入国家免疫规划的常规疫苗接种范围,但接种率仍不理想。这表明在不同国家实施 HPV 免疫规划可能存在挑战。本系统文献综述 (SLR) 的目的是确定全球国家和地区免疫规划中 HPV 疫苗接种的实施策略,旨在为旨在提高 HPV 疫苗覆盖率 (VCR) 的国家提供指导。对 Medline 和 Embase 进行了全面的文献检索,纳入了 2012 年 1 月至 2022 年 1 月期间发表的文章。在检索到的 2549 篇文章中,有 168 篇符合纳入标准并纳入了综述。文献中显示可提高 HPV 疫苗接种率的策略包括提高社区对 HPV 的认识和了解的宣传活动、医护人员培训、在学校环境中整合 HPV 疫苗接种、通过多部门伙伴关系进行协调努力,以及疫苗接种提醒和召回系统。研究结果可能有助于国家当局在设计和实施旨在提高青少年 HPV VCR 的项目时,了解 HPV 疫苗接种的关键考虑因素。